Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2012
06/21/2012US20120157526 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
06/21/2012US20120157476 Oxime compounds
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120156300 Microbubbles and methods for oxygen delivery
06/21/2012US20120156296 Antioxidants in fish oil powder and tablets
06/21/2012US20120156294 Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156278 Systems and methods for preparing autologous fibrin glue
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156187 Methods and compositions for modulation of blood-neural barrier
06/21/2012US20120156181 Therapeutic agent for liver-related diseases
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156170 Drug composition for angiogenesis therapy
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012DE102010063127A1 Flüssige, oral applizierbare pharmazeutische Zusammensetzungen enthaltend Liquid, orally administrable pharmaceutical compositions containing 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
06/21/2012CA2819108A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration
06/21/2012CA2787164A1 Compound sea cucumber product, preparation method, and dosage forms thereof
06/21/2012CA2787154A1 A compound sea cucumber preparation and manufacturing method thereof
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464369A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464352A1 Use of e5501 for stimulating platelet production
06/20/2012EP2464333A2 Floating microgranules
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2222312B1 Aqueous iron dextran preparation having one or more para-hydroxybenzoate compounds and/or salts thereof
06/20/2012EP1765411B1 Polymer-factor ix moiety conjugates
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504005A Compound with novel structure and preparation method and applications thereof
06/20/2012CN102499996A Fibrous membrane for non-virus gene treatment and preparation method thereof
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102100843B Chinese medicine composition for treating virgin metrorrhagia and metrostaxis and using method thereof
06/20/2012CN101879251B Composition for improving aplastic anemia symptoms as well as preparation method and application thereof
06/20/2012CN101874818B Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
06/20/2012CN101684151B Protein matter with coagulation activity
06/20/2012CN101612385B Application of rLZ-8 in treating thrombopenia and preparation thereof
06/20/2012CN101596221B Process for preparing water-soluble ginkgo biloba extract used for injection
06/20/2012CN101332222B Decoction for treating chronic bronchitis hemoptysis
06/20/2012CN101204225B Medical food with the function of enriching blood and moistening lung
06/20/2012CN101185509B Medicinal food for spleen-invigorating and blood-nourishing
06/20/2012CN101163510B Virus inactivation method, processing system and device used therein
06/19/2012USRE43481 Diazepan derivatives or salts thereof
06/19/2012US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells
06/19/2012CA2685219C Diazaquinolones that inhibit prolyl hydroxylase activity
06/19/2012CA2523844C Stable thrombin composition
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2314610C Method for preparing by filtration a virally secure factor viii solution
06/14/2012WO2012075678A1 Substituted thiazolyl pyrazolo pyridine compound and medicinal use thereof
06/14/2012US20120150087 Solid dressing for treating wounded tissue
06/14/2012US20120149778 Compounds
06/14/2012US20120149764 Aptamers that bind thrombin with high affinity
06/14/2012US20120149758 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
06/14/2012US20120149749 Method of treating thrombocytopenia
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149727 Prasugrel in non-crystalline form and pharmaceutical composition thereof
06/14/2012US20120149712 Methods for improving kidney function
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149694 Substituted piperidines
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149643 Safe Desmopressin Administration
06/14/2012US20120148688 Prevention of thrombus formation and/or stabilization
06/14/2012US20120148658 Solid dressing for treating wounded tissue
06/14/2012US20120148603 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148557 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148528 Compositions and methods to induce targeted apoptosis
06/14/2012US20120148522 Biocompatible Polyelectrolyte Complexes and Methods of Use
06/14/2012DE102010062544A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, pulmonary hypertension and vascular disease
06/13/2012EP2463290A1 Thienooxazepine derivative
06/13/2012EP2462145A1 Prasugrel in non-crystalline form and pharmaceutical composition thereof
06/13/2012EP1745076B1 Antibodies specific for glycoprotein vi and methods of producing these antibodies
06/13/2012EP1609804B1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme
06/13/2012CN102497877A Modified erythropoietin to which water-soluble long-chain molecule is added
06/13/2012CN102492043A Anti-tumor and thrombolytic dual-effect chimeric protein with low immunogenicity, its preparation method and application
06/13/2012CN102491979A 1-hydroxyethyl-5-substituted indolone derivative and preparation method and application thereof
06/13/2012CN102488794A Medicine used for treating antibiotic-resisting bacteria co-infection of blood disease patients
06/13/2012CN102488786A Chinese angelica capsule for enriching blood
06/13/2012CN102488783A Symptom Chinese patent medicine for blood deficiency
06/13/2012CN102488764A Preparation method for total saponins of Rubus parviflolius
06/13/2012CN102488742A Preparation method of astragaloside
06/13/2012CN102488713A Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution
06/13/2012CN102488710A Method for extracting thrombin antagonist from pig plasma
06/13/2012CN102488698A Oral treatment water
06/13/2012CN102488696A Glycerin-fructose composition injection and its preparation method
06/13/2012CN102488663A Drug combination containing ethylenediamine diaceturate and preparing method thereof
06/13/2012CN102210703B Dextran of polypeptide donkey-hide gelatin
06/13/2012CN102145067B Traditional Chinese medicine capsule for treating bone marrow suppression caused by highly active antiretroviral therapy (HAART) for AIDS (acquired immure deficiency syndrome)
06/13/2012CN101961459B Oral medicament for treating hemiplegia
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 671